Ezetimibe Tablet
Product Images NDC 0591-3713

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 0591-3713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

FDA Label Image

10 mg (Image 2)

10 mg (Image 2)
This is a medication called Ezetimibe, available in tablet form, with each tablet containing 10mg of the medication. The usual dosage is one tablet per day. It is manufactured in India by Watson Pharma Private Limited and distributed by Actavis Pharma, Inc. The medication should be stored in a controlled room temperature of 20°C to 25°C and protected from moisture. The lot number is 0591-3713-30 and it is available only on prescription. Additionally, the pharmacist is required to dispense the Patient Information leaflet to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.